Applications
Click
here to download this page in PDF format.
Click here to download
Golgi staining and analysis is a
valuable tool in the neurostructural assessment of dendritic parameters for
studies related to:
- Neurodegeneration, Alzheimer’s
Disease, Brain Aging
- Neuroplasticity/Neuroregenerative
Processes
- Morphological Basis of Cognitive
Dysfunction or Cognitive Enhancement
- Neuroprotection
- Assessment of Genetic Manipulations:
Knock-Outs, Mutants, Transgenics…
- Neurotoxicology
- Brain Development
- Neuropathology
An overview of some of the applications
are shown below. For additional information Click
here to see abstracts from recent scientific meetings and publications.
- Brain Aging, Alzheimer’s Disease, Neurodegenerative
Disorders
Assess extent of dendritic atrophy and spine
loss
Evaluate the effects of cognitive enhancers,
nerve growth factors, neurotrophins, environmental enrichment or other factors
resulting in possible neuroplasticity which might ameliorate or reverse
the neurodegeneration or damage (new dendritic branching, increased spine
density, changes in spine configuration)

Normal
Cerebellar Purkinje Cell

Purkinje cell showing
age-related dendritic atrophy
- Abnormal or Dysmorphic Aspects of Brain
Development
- Assess the role of neurotoxins, drugs, alcohol,
viruses, or environmental manipulations on dendritic development, spine
formation, pruning of the dendritic arbor and normal spine changes

Camera lucida drawing of normal granule cell of the
rat dentate Gyrus

Camera lucida drawing of damaged granule cell neuron from neonatal rat infected
with Borna disease virus
In
the graph below we see the effect of neonatal infection of rat brain with
Borna disease virus on estimated total dendritic length, granule cells of
the dentate gyrus, (borna disease virus-infected vs. controls)

- Knock-outs, Transgenics, Mutants, Knock-ins
Subtle changes in genotype and genomic expression
can affect neuronal morphology, often leading to neuronal atrophy or neurodegeneration.
Changes in dendritic neurostructure can alter regional brain circuitry and
ultimately influence behavior (learning and/or memory). Below are representative
examples of findings from some of our studies in this area.
- The figures below show some findings of an
animal model of Alzheimer’s disease: transgenic mice which overexpress human
amyloid precursor protein (hAPP)

Transgenic PDAPP mice overexpress human
amyloid precursor protein. This results in dendritic atrophy in hippocampus
and dentate gyrus. This figure shows a comparison of camera lucida drawings
of normal control granule cells and atrophic granule cells of the dentate
gyrus in the transgenic mice.

PDAPP tg mice develop senile plaques. Golgi studies
show that there is abnormal neuritic sprouting within the plaque. This figure
shows a camera lucida drawing of such aberrant sprouting within a plaque.
Another example of the value of Golgi analysis
in mutant mice is seen in evaluation of compound heterozygous, tottering/leaner
mice (tg/tgla), which exhibit abnormal phenotypic expression
, including ataxia,. These mice were found to have cerebella with Purkinje
cells having smaller dendritic arbors and significant spine loss.

This figure shows a normal Purkinje cell from the
cerebellum of a wild-type control

This grossly dysmorphic Golgi stained
Purkinje cell was representative of those widely found thoughout the cerebellum
of the tottering/leaner mouse.
An animal model of human lissencephaly was
developed in which there was a heterozygous deletion of the Lis1 gene. During
brain development these Lis1 deficient mice showed abnormal neuronal migration
which resulted in hippocampal disorganization accompanied by dendritic atrophy
of CA1 pyramids which had not migrated to their proper location in stratum
pyramidale. This resulted in the data shown in the figure below.

Sparce fur (spf/Y) mice mice have a
ornithine carbamoyltransferase deficiency, an X-linked trait, which leads
to toxic hyperammonemia. Our Golgi studies clearly showed that this genetic
deficiency resulted in cortical pyramids with smaller dendritic trees and
spine loss. These changes are seen in the camera lucida drawings below.

Figure A is a camera lucida drawing of the basilar
tree of a normal layer V pyramidal cell.

Figure B, a layer V cortical pyramid from a sparce
fur mouse. The dendritic atrophy and spine loss seen in these animals is apparent.
Subtle influences of chronic and subchronic exposure
to environmental neurotoxins on various regions of the developing, adult, or
aging brain can be assessed.
- In the figure below, as assessed by our Golgi
studies, prenatal exposure to increasing doses of tetrachloroazobenzene
(TCAB) in Sprague-Dawley rats resulted in progressively increasing dendritic
atrophy of layer V pyramids.

The figure below shows the neurotoxic effect
of gp120 – a glycoprotein associated with the shell of the human immunodeficiency
virus (HIV) – on dendritic morphology in the rat. Note the swollen portions
along the dendrite segment and the patchy loss of dendritic spines as early
signs of neuronal damage.

Prenatal exposure of PCBs (polychlorinated
biphenyls) has also been broadly associated with neurotoxic consequences.
From analysis of Golgi impregnated neurons we show in the graph below that
PCB exposure in rats resulted in reduced numbers of dendritic spines on
hippocampal CA1 pyramids.

Applications of Golgi studies include:
- Early and progressive effects of neuronal
injury can be tracked in longitudinal studies
- Sublethal injury in neurons located in the
penumbra or distal to immediate trauma zone can evaluated;
- Initial damage (atrophic changes) followed
by normal or drug-enhanced neuroplastic restoration of branching and spines)
can be quantified
- Neuroprotection can be quantified both in
terms of to individual neurons as well as with respect to area/volume of
infarct or trauma.
- The relationship of damage to neurons in the
infarcted or damaged hemisphere can also be evaluated in terms of changes
to neurons in the contralateral (undamaged) hemisphere.
- The area or volume of damage (e.g., of infarct
in a stroke model) can be measured along with changes in neurons within
the infarct, in the penumbral zone, or distal to the infarct.

Appearance of damaged pyramidal
neuron following middle cerebral artery occlusion. Dendritic atrophy, spine
loss, and branch swellings can be seen.
- Clinical and Experimental Neuropathology
Clinical tissue with reasonably short post-mortem
interval to fixation (usually less than 8 hours) can be evaluated to assist
in the assessment of neurological and genetic disorders.

The above figure shows the appearance of a highly
dystrophic Golgi-stained Purkinje cell from the brain of a 3 year-old who
was infected with HIV. This child, whose mother was HIV-positive, showed significant
neurological involvement and delayed developmental milestones prior to death.
- Evaluation of animal models of human neurologic
disorders.
For additional examples of these various applications
click
here to see abstracts from some recent representative publications
and presentations at scientific conferences
A
Partial Listing of Collaborative Institutions and Research Partners
:
- The Scripps Research Institute, LaJolla,
CA
- University of California, Irvine
- Columbia University College of Physicians
& Surgeons
- Yale University School of Medicine
- NIH – NICHD
- Institute Curie, INSERM, France
- Environmental Protection Agency (EPA)
- NIH – National Institute of Alcohol Abuse
and Alcoholism (NIAAA)
- NIH – The National Human Genome Research
Institute (NHGRI)
- Oregon Health Sciences University
- Loyola University Medical Center- Chicago
- The University of Louisville Medical Center
- NIH -- National Institute of Environmental
Health Sciences (NIEHS)
- NIH -- National Institute for Child Health
and Human Development (NICHD)
- The Centers for Disease Control (CDC),
National Institute for Occupational Safety and Health (NIOSH)
- Elan Pharmaceuticals
- Cornell University Medical Center
- Genzyme Corporation
- Hebrew University, Jerusalem
- LSU Medical Center, New Orleans
- University of Maryland, Institute of Human
Virology
Back
to Our Services

Home | Our
Services | Applications
| Representative Abstracts
| Contact Us
ArtNeuro©Micrographs |
Support Our Lab | Website
Directory

Ronald F. Mervis,
Ph.D.
Neurostructural Research Laboratories, Inc.
12409 Telecom Drive
Telecom Technology Park
Tampa, FL 33637 USA
Phone: 813-977-5400; Fax: 813-977-5444; Cell: 813-786-5668
E mail: RonMervis@neurostructural.org
(or) RonMervis@aol.com
Website: www.neurostructural.org
Copyright
© 2001 - 2010 NeuroStructural Research Laboratories. All rights reserved.